Literature DB >> 28899050

Advances in Genomics Explain Medulloblastoma Behavior at the Bedside.

Claudia M Kuzan-Fischer1,2, Ana S Guerreiro Stucklin1,2,3, Michael D Taylor1,2,4,5.   

Abstract

Entities:  

Year:  2017        PMID： 28899050     DOI： 10.1093/neuros/nyx248

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  3 in total

1.  A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.

Authors:  Jezabel Rodriguez-Blanco; Bin Li; Jun Long; Chen Shen; Fan Yang; Darren Orton; Sara Collins; Noriyuki Kasahara; Nagi G Ayad; Heather J McCrea; Martine F Roussel; William A Weiss; Anthony J Capobianco; David J Robbins
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

2.  Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.

Authors:  Jiajia Wang; Yi Sui; Qifeng Li; Yang Zhao; Xiaoshu Dong; Jian Yang; Zhuangzhuang Liang; Yipeng Han; Yujie Tang; Jie Ma
Journal:  Cell Death Dis       Date:  2020-12-02       Impact factor: 8.469

Review 3.  Medulloblastoma in the Molecular Era.

Authors:  Claudia Miranda Kuzan-Fischer; Kyle Juraschka; Michael D Taylor
Journal:  J Korean Neurosurg Soc       Date:  2018-05-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.